↓ Skip to main content

Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT

Overview of attention for article published in EJNMMI Research, March 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#6 of 474)
  • High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

1 news outlet
8 tweeters


36 Dimensions

Readers on

30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT
Published in
EJNMMI Research, March 2017
DOI 10.1186/s13550-017-0278-z
Pubmed ID

Antonios Tzortzakakis, Ove Gustafsson, Mattias Karlsson, Linnea Ekström-Ehn, Rammin Ghaffarpour, Rimma Axelsson


Despite the progress in the quality of multiphasic CT and MRI scans, it is still difficult to fully characterize a solid kidney lesion. Approximately 10% of all solid renal tumours turn out to be oncocytomas. In actual clinical practice, this is verified only following unnecessary surgery or a renal biopsy/ablation. The objective of our pilot study examines whether (99m)Tc-sestamibi SPECT/CT can play a crucial role in the characterization of solid renal neoplasms and the differentiation of oncocytomas from renal cell carcinomas. The study included 27 patients identified with 31 solid renal lesions. All patients were discussed in a multidisciplinary conference, and a decision for surgery or biopsy was taken. Prior to invasive procedures, patients underwent a SPECT/CT with (99m)Tc-sestamibi. Visual evaluation was performed, and any focal (99m)Tc-sestamibi uptake detected on SPECT in the localisation of tumour was considered as positive. Eleven out of 12 oncocytomas (91.6%) displayed positive uptake of (99m)Tc-sestamibi. Three hybrid tumours (mixed-type oncocytoma and chromophobe renal cancer) were positive on SPECT/CT. One papillary renal cell carcinoma had a slight uptake of (99m)Tc-sestamibi. The remaining 11 renal cell carcinomas were sestamibi negative. Differentiation of benign renal oncocytomas from renal cell carcinomas seems very promising on (99m)Tc-sestamibi SPECT/CT examination. Additional supplement to visual evaluation, i.e. quantitative tools, should be sought for an accurate estimate of biological behaviour and hence a secure diagnosis.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 23%
Student > Doctoral Student 5 17%
Other 4 13%
Researcher 3 10%
Student > Master 2 7%
Other 5 17%
Unknown 4 13%
Readers by discipline Count As %
Medicine and Dentistry 22 73%
Business, Management and Accounting 1 3%
Nursing and Health Professions 1 3%
Unknown 6 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2018.
All research outputs
of 19,229,245 outputs
Outputs from EJNMMI Research
of 474 outputs
Outputs of similar age
of 277,041 outputs
Outputs of similar age from EJNMMI Research
of 1 outputs
Altmetric has tracked 19,229,245 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 474 research outputs from this source. They receive a mean Attention Score of 2.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them